Local intracranial delivery of HER2 CAR T cells with either a 4-1BB or CD28 costimulatory domain eliminated brain metastases and extended survival past 100 days post tumor implantation, whereas control mice did not survive past 35 days of treatment. The gene discussed is ERBB2; the disease is neoplasm.